Evaluation of empiric antibiotic use in surgical sepsis

American Journal of Surgery

Volumn 200, Issue 6, 2010, Pages 776-782

  Fitousis, Kalliopi ^a   Moore, Laura Jane ^a   Hall, Jeffery ^a   Moore, Frederick A ^a   Pass, Steven ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

Antimicrobial therapy; Computerized clinical decision support; Sepsis; Surgical sepsis

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACCURACY; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CANDIDEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG SCREENING; DRUG SUBSTITUTION; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING FASCIITIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SURGICAL INFECTION; SURGICAL SEPSIS; TREATMENT INDICATION; URINARY TRACT INFECTION; UROSEPSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 78650198237     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.09.001     Document Type: Article

References (12)

1. R.P. Dellinger, M.M. Levy, and J.M. Carlet Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock Crit Care Med 36 2008 1394 1396
2. G.S. Martin, D.M. Mannino, and S. Eaton The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
3. D.A. Angus, W.T. Linde-Zwirble, and J. Lidicker Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
4. J.E. Parrillo, M.M. Parker, and C. Natanson Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy Ann Intern Med 113 1990 227 242
5. R.P. Dellinder, J.M. Carlet, and H. Masur Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Crit Care Med 32 2004 858 869
6. A. Marcus, and D. Bronstein New surviving sepsis' data tie bundles to fewer deaths Pharmacy practice News 36 2009 1 8
7. L.J. Moore, S.L. Jones, and L.A. Kreiner Validation of a screening tool for the early identification of sepsis J Trauma 66 2009 1539 1546
8. M.H. Kollef, G. Sherman, and S. Ward Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
9. J. Garnacho-Montero, J.L. Garcia-Garmendia, and A. Barrero-Almodovar Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis Crit Care Med 31 2003 2742 2751
10. E.H. Ibrahim, G. Sherman, and S. Ward The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting Chest 118 2000 146 155
11. C.M. Luna, P. Vujacich, and M.S. Niederman Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia Chest 111 1997 676 685
12. R.S. Evans, D.C. Classen, and S.L. Pestotnik Improving empiric antibiotic selection using computerized decisions Arch Intern Med 154 1994 878 884